Vizient applauds FDAs recent actions to accelerate biosimilar development and lower costs

Published on October 30, 2025

The announcement underscores the agency's commitment to expanding patient access to affordable biologic therapies while maintaining safety and efficacy.

Continue reading on website
Other news

Healthcare expertise Good news bad news and difficult decisions

October 29, 2025
Amid shifting perceptions of healthcare expertise, board and C-suite leaders must define the basic principles of their organization and its role in medicine, patient care and public health and consider how they will make decisions when these principles might conflict with current perceptions.

Vizient analysis finds tenfold increase in colorectal cancer screenings among adults aged 45-49

November 4, 2025
The analysis, conducted using data from the Vizient Clinical Data Base, found that screenings in this younger age group increased nearly tenfold after the U.S. Preventive Services Task Force (USPSTF) updated its guidelines in 2021, reflecting rapid adoption by hospitals and health systems across the country.